SynthesisBreast cancer research and treatment2024

The association between HER2-low status and survival in patients with metastatic breast cancer treated with Cyclin-dependent kinases 4 and 6 inhibitors: a systematic review and meta-analysis.

Deniz Can Guven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.